117 related articles for article (PubMed ID: 8948507)
1. Thromboxane A2 stimulates mitogen-activated protein kinase and arachidonic acid liberation in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Prostaglandins; 1996 Nov; 52(5):403-13. PubMed ID: 8948507
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
3. Increased cytosolic phospholipase A2 activity is not accompanied by arachidonic acid liberation in U46619-stimulated rabbit platelets.
Akiba S; Abe T; Sato T
Biochem Mol Biol Int; 1995 Feb; 35(2):275-81. PubMed ID: 7663381
[TBL] [Abstract][Full Text] [Related]
4. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
Okwu AK; Mais DE; Halushka PV
Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
[TBL] [Abstract][Full Text] [Related]
5. Low-affinity thromboxane receptor mediates proliferation in cultured vascular smooth muscle cells of rats.
Ko FN
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1274-82. PubMed ID: 9261257
[TBL] [Abstract][Full Text] [Related]
6. Dissociation between the phospholipases C and A2 activities in stimulated platelets and their involvement in the arachidonic acid liberation.
Faili A; Emadi S; Vargaftig BB; Hatmi M
Br J Haematol; 1994 Sep; 88(1):149-55. PubMed ID: 7803237
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets.
Nakano T; Hanasaki K; Arita H
J Biol Chem; 1989 Apr; 264(10):5400-6. PubMed ID: 2494164
[TBL] [Abstract][Full Text] [Related]
9. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue.
Saklatvala J; Rawlinson L; Waller RJ; Sarsfield S; Lee JC; Morton LF; Barnes MJ; Farndale RW
J Biol Chem; 1996 Mar; 271(12):6586-9. PubMed ID: 8636072
[TBL] [Abstract][Full Text] [Related]
10. Reduced thromboxane receptor affinity and vasoconstrictor responses in placentae from diabetic pregnancies.
Wilkes BM; Mento PF; Hollander AM
Placenta; 1994 Dec; 15(8):845-55. PubMed ID: 7886025
[TBL] [Abstract][Full Text] [Related]
11. Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets.
Astarie-Dequeker C; Korichneva I; Devynck MA
Br J Pharmacol; 1995 Jan; 114(2):524-30. PubMed ID: 7881751
[TBL] [Abstract][Full Text] [Related]
12. Involvement of phospholipase C-gamma2 in activation of mitogen-activated protein kinase and phospholipase A2 by zooxanthellatoxin-A in rabbit platelets.
Rho MC; Nakahata N; Nakamura H; Murai A; Ohizumi Y
J Pharmacol Exp Ther; 1997 Jul; 282(1):496-504. PubMed ID: 9223592
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 and vascular smooth muscle cell proliferation.
Sachinidis A; Flesch M; Ko Y; Schrör K; Böhm M; Düsing R; Vetter H
Hypertension; 1995 Nov; 26(5):771-80. PubMed ID: 7591017
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 mimetic U46619 stimulates ciliary motility of rabbit tracheal epithelial cells.
Chiyotani A; Tamaoki J; Sakai N; Isono K; Kondo M; Konno K
Prostaglandins; 1992 Feb; 43(2):111-20. PubMed ID: 1311864
[TBL] [Abstract][Full Text] [Related]
15. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
16. Vascular smooth muscle thromboxane A2 receptors mediate arachidonic acid-induced sudden death in rabbits.
Pfister SL; Kotulock DA; Campbell WB
Hypertension; 1997 Jan; 29(1 Pt 2):303-9. PubMed ID: 9039119
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen.
Grosser T; Zucker TP; Weber AA; Schulte K; Sachinidis A; Vetter H; Schrör K
Eur J Pharmacol; 1997 Jan; 319(2-3):327-32. PubMed ID: 9042608
[TBL] [Abstract][Full Text] [Related]
18. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
[TBL] [Abstract][Full Text] [Related]
19. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
20. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
